DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsHighNegative
Announced Tue, 14 Apr · 21:17 IST

Dr. Reddy's Laboratories Limited has informed the Exchange about Dr. Reddy s Laboratories LLC, Russia, a step-down wholly-owned subsidiary has received a final penalty decision from the Tax Authority.

Regulatory & Legal View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹1234.30
prior close
₹1220.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-1.6-1.3-0.5-1.0+0.3-0.3-1.1-1.4+6.4+5.8+8.8+3.6-0.4
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories LLC, Russia (a step-down wholly-owned subsidiary) received a final penalty decision from the Interdistrict Inspectorate of the Federal Tax Service of Russia on April 13, 2026. The penalty relates to VAT being levied upon re-classification of marketing services as taxable services. The penalty amount was reduced to RUB 9.27 million (approximately INR 11.40 million) from the original quantified amount of RUB 20.09 million (approximately INR 24.50 million). The company states this penalty has no material impact on its financials, operations, or other activities.

Likely market impact

The penalty amount is relatively small (INR 11.40 million) compared to Dr. Reddy's scale, and the company has confirmed no material impact. However, it represents an adverse regulatory outcome in a foreign jurisdiction that investors may want to monitor.